NCT04856306View on ClinicalTrials.gov

Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

August 30, 2025

Conditions
Heavy Menstrual BleedingFibroid Uterus
Interventions
OTHER

Groups 1 and 2 myomectomy and uterine artery embolization, respectively, are surgical/procedure

See previous descriptions

DRUG

Elagolix Oral Product

See group 3 description

Trial Locations (1)

20010

MedStar Washington Hospital Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER